ReviewFrontiers in genetics2026
Emerging genetic mechanisms of glomerular proteinuria: a podocyte-centered multi-layer network perspective.
Review in Frontiers in genetics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Podocyte injury is widely recognized as a central driver of glomerular proteinuria and progression to chronic kidney disease. Although proteinuria can originate from multiple components of the glomerular filtration barrier, genetic and experimental studies increasingly implicate podocyte dysfunction as a dominant and convergent mechanism in many disease contexts. In recent years, the application of next-generation sequencing has broadened the spectrum of genes linked to proteinuric kidney disorders. These genes are no longer confined to structural elements of the slit diaphragm or cytoskeleton but also involve pathways governing vesicular trafficking, nuclear regulation, mitochondrial function, and interactions with the extracellular matrix. Despite their functional diversity, alterations in these pathways often produce overlapping clinical phenotypes, suggesting convergence at the level of cellular homeostasis rather than at a single molecular endpoint. Experimental observations further indicate that podocytes maintain their structural and functional integrity through coordinated regulation across multiple cellular compartments. Mechanical cues originating from the glomerular basement membrane are interpreted through cytoskeletal signaling; membrane trafficking processes determine the localization and turnover of key slit diaphragm proteins; nuclear mechanisms shape transcriptional responses; mitochondrial systems contribute to metabolic adaptation under stress conditions. Perturbations in any of these processes may not remain localized but can extend across interconnected pathways, gradually impairing filtration barrier function. Current evidence therefore favors a multi-layer network perspective in which glomerular proteinuria reflects a breakdown of coordinated podocyte homeostasis across interconnected cellular compartments.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.